Amgen Inc. Files 8-K for Security Holder Vote

TL;DR

Amgen's voting on important stuff soon, keep an eye out.

AI Summary

On May 23, 2025, Amgen Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific details of the matters to be voted on, but it indicates that a vote will take place.

Why It Matters

This filing signals an upcoming shareholder meeting where important corporate decisions will be put to a vote, potentially impacting the company's future direction.

Risk Assessment

Risk Level: low — The filing is a routine procedural disclosure and does not contain information that inherently increases risk.

Key Players & Entities

• Amgen Inc. (company) — Registrant
• May 23, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-37702 (commission_file_number) — SEC File Number
• 95-3540776 (irs_ein) — IRS Employer Identification No.
• One Amgen Center Drive (address) — Principal Executive Offices
• Thousand Oaks (city) — Principal Executive Offices
• California (state) — Principal Executive Offices
• 91320-1799 (zip_code) — Principal Executive Offices
• (805) 447-1000 (phone_number) — Registrant's Telephone Number

FAQ

From the Filing

0000950170-25-077233.txt : 20250527 0000950170-25-077233.hdr.sgml : 20250527 20250523185528 ACCESSION NUMBER: 0000950170-25-077233 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20250523 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250527 DATE AS OF CHANGE: 20250523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 25983814 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 8-K 1 amgn-20250523.htm 8-K 8-K false 0000318154 0000318154 2025-05-23 2025-05-23 0000318154 amgn:A2.00SeniorNotesDue2026Member 2025-05-23 2025-05-23 0000318154 us-gaap:CommonStockMember 2025-05-23 2025-05-23   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025     Amgen Inc. (Exact name of Registrant as Specified in Its Charter)     Delaware 001-37702 95-3540776 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)           One Amgen Center Drive   Thousand Oaks , California   91320-1799 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: (805) 447-1000     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, $0.0001 par value   AMGN   The Nasdaq Global Select Market 2.00% Senior Notes due 2026   AMGN26   The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 5.07. Submission of Matters to a Vote of Security Holders. The Company held its Annual Meeting on May 23, 2025. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company’s 2026 annual meeting of stockholders and until his or her successor is elected and qualified, or until his or her earlier retireme